Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
MYL1 (human)
p Phosphorylation
a Acetylation
m Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
u Ubiquitination
s Sumoylation
n Neddylation
g O-GlcNAc
h Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage

Overview
MYL1 Regulatory light chain of myosin. Does not bind calcium. 2 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Protein type: Motility/polarity/chemotaxis; Contractile protein
Cellular Component: sarcomere; myofibril; muscle myosin complex; cytosol
Molecular Function: structural constituent of muscle; calcium ion binding
Biological Process: muscle development; muscle contraction; muscle filament sliding; cardiac muscle contraction
Reference #:  P05976 (UniProtKB)
Alt. Names/Synonyms: A1 catalytic; A2 catalytic; MLC1/MLC3; MLC1F; MLC1F/MLC3F; MLC3F; MYL1; Myosin light chain 1/3, skeletal muscle isoform; Myosin light chain A1/A2; Myosin light chain alkali 1/2; myosin, light chain 1, alkali; myosin, light polypeptide 1, alkali; skeletal, fast
Gene Symbols: MYL1
Molecular weight: 21,145 Da
Basal Isoelectric point: 4.97  Predict pI for various phosphorylation states
CST Pathways:  Regulation of Actin Dynamics
Select Structure to View Below

MYL1

Protein Structure Not Found.


STRING  |  Scansite  |  Phospho.ELM  |  Pfam  |  DISEASE  |  Source  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 2 K8 MAPKKDVKKPVAAAA
0 2 K9 APKKDVKKPVAAAAA
0 2 K32 APAPAPAKPKEEKID
0 1 K32 APAPAPAKPKEEKID
0 2 K34 APAPAKPKEEKIDLS
0 2 K37 PAKPKEEKIDLSAIK
0 2 K44 KIDLSAIKIEFSKEQ
0 1 K44 KIDLSAIKIEFSKEQ
0 2 K49 AIKIEFSKEQQDEFK
0 1 K49 AIKIEFSKEQQDEFK
0 2 K56 KEQQDEFKEAFLLFD
0 2 K56 KEQQDEFKEAFLLFD
0 1 T65-p AFLLFDRtGDsKITL
0 1 S68-p LFDRtGDsKITLsQV
0 2 K69 FDRtGDsKITLsQVG
0 1 K69 FDRtGDsKITLsQVG
0 2 T71 RtGDsKITLsQVGDV
0 2 S73-p GDsKITLsQVGDVLR
0 2 R92 NPTNAEVRKVLGNPs
0 1 R92 NPTNAEVRKVLGNPs
0 2 K93 PTNAEVRKVLGNPsN
0 2 S99-p RKVLGNPsNEELNAK
0 2 K106 sNEELNAKKIEFEQF
0 2 K106 sNEELNAKKIEFEQF
0 2 K107 NEELNAKKIEFEQFL
0 1 K107 NEELNAKKIEFEQFL
0 1 K124 MQAISNNKDQATYED
0 1 Y129 NNKDQATYEDFVEGL
0 2 K141-u EGLRVFDkEGNGTVM
0 9 K162-a VLATLGEkMKEEEVE
0 1 K162 VLATLGEKMKEEEVE
0 1 K164 ATLGEkMKEEEVEAL
0 1 Y184 DSNGCINYEAFVKHI
  mouse

 
K8-u MAPKKDVkkPAAAPA
K9-u APKKDVkkPAAAPAP
K26-u APAPAPAkPkEEkID
K26-a APAPAPAkPkEEkID
K28-u APAPAkPkEEkIDLS
K31-u PAkPkEEkIDLSAIk
K38-u kIDLSAIkIEFSkEQ
K38-a kIDLSAIkIEFSkEQ
K43-u AIkIEFSkEQQEDFk
K43-a AIkIEFSkEQQEDFk
K50-a kEQQEDFkEAFLLFD
K50-u kEQQEDFkEAFLLFD
T59 AFLLFDRTGECkItL
C62 LFDRTGECkItLSQV
K63-u FDRTGECkItLSQVG
K63-a FDRTGECkItLSQVG
T65-p RTGECkItLSQVGDV
S67 GECkItLSQVGDVLR
K86-a NPTNAEVkkVLGNPS
K86-u NPTNAEVkkVLGNPS
K87-u PTNAEVkkVLGNPSN
S93 kkVLGNPSNEEMNAk
K100-a SNEEMNAkkIEFEQF
K100-u SNEEMNAkkIEFEQF
K101-u NEEMNAkkIEFEQFL
K101-a NEEMNAkkIEFEQFL
K118-u MQAISNNkDQGGyED
Y123-p NNkDQGGyEDFVEGL
K135-u EGLRVFDkEGNGTVM
K156-a VLATLGEkMkEEEVE
K156-u VLATLGEkMkEEEVE
K158-u ATLGEkMkEEEVEAL
Y178-p DSNGCINyEAFVKHI
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.